Related Experiment Video
Updated: Mar 5, 2026
08:42
Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
11.7K
Valproic acid malabsorption in 30 year-old female patient - Case study
Anna Jopowicz1, Agnieszka Piechal2, Iwona Kurkowska-Jastrzębska1
1Instytut Psychiatrii i Neurologii/Institute of Psychiatry and Neurology, Warsaw, Poland.
Neurologia I Neurochirurgia Polska
|March 26, 2017
Summary
Drug formulation significantly impacts valproic acid absorption. Changing the formulation improved bioavailability and patient condition in a case of epilepsy treatment failure due to malabsorption.
Area of Science:
- Pharmacology
- Clinical Pharmacy
Background:
- Valproic acid (VPA) is a long-established treatment for epilepsy and bipolar disorder.
- Its pharmacokinetic profile is generally understood, but formulation-dependent gastrointestinal absorption is often overlooked.
Observation:
- A 30-year-old female with juvenile myoclonic epilepsy experienced treatment failure due to malabsorption of sodium valproate and valproic acid.
- Standard formulations led to ineffective drug levels.
Findings:
- Altering the drug formulation dramatically increased valproic acid bioavailability.
- This modification resulted in a partial improvement of the patient's clinical symptoms.
Implications:
- Extremely low therapeutic drug levels may indicate malabsorption, not just poor compliance.
- Drug formulation is a critical factor influencing valproic acid absorption and treatment efficacy.
- Optimizing drug formulation can enhance absorption and improve therapeutic outcomes in patients with malabsorption issues.
Related Concept Videos
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
1.1K
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
1.1K
01:31Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
785
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
785
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
1.6K
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.6K
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
722
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
722
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
195
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
195
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
283
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
283